buprenorphine hydrochloride
NDC 0121-1019, buprenorphine hydrochloride, tablet, from PAI Holdings, LLC dba PAI Pharma.
- Product NDC
- 0121-1019
- Status
- Listed
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090622
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0121-1019-30 | 00121101930 | 30 TABLET in 1 BOTTLE (0121-1019-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/442831cf-9636-433a-9a12-e9a8cd31f72aNADAC price for package 00121101930
GET /v1/drugs/nadac/00121101930
Use it
Look up 0121-1019 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0121-1019. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.